Bag Remzi, Suleman Nizar, Guntupalli Kalpalatha K
Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, Texas 77030, USA.
Curr Opin Pulm Med. 2004 Sep;10(5):412-8. doi: 10.1097/01.mcp.0000136404.09581.41.
Respiratory failure associated with interstitial lung disease (ILD) occurs commonly, often as a terminal event after a prolonged course of illness. Diagnosis and management of the underlying ILD and respiratory failure pose great challenges.
Respiratory failure in the absence of a clearly identifiable cause has a high mortality and frequent complications. Patients with idiopathic pulmonary fibrosis who are admitted with respiratory failure have a grim prognosis and may not benefit from prolonged aggressive therapy including mechanical ventilation. Presence of diffuse alveolar damage or usual interstitial pneumonia on lung biopsy specimens from patients with respiratory failure may be a marker of poor prognosis. Recently, the importance of the clinical-radiologic-pathologic diagnosis has been emphasized.
The prognosis and treatment may vary according to the type of ILD and the cause of the respiratory failure, which must therefore be established before treatment is initiated. Prevention of iatrogenesis and timely application of palliation are as important as specific treatment of underlying ILD.
间质性肺疾病(ILD)相关的呼吸衰竭很常见,通常是在病程延长后的终末事件。潜在ILD和呼吸衰竭的诊断与管理面临巨大挑战。
无明确可识别病因的呼吸衰竭死亡率高且并发症频繁。因呼吸衰竭入院的特发性肺纤维化患者预后不佳,可能无法从包括机械通气在内的长期积极治疗中获益。呼吸衰竭患者肺活检标本中存在弥漫性肺泡损伤或普通型间质性肺炎可能是预后不良的标志。最近,临床-放射学-病理学诊断的重要性得到了强调。
预后和治疗可能因ILD类型及呼吸衰竭病因而异,因此在开始治疗前必须明确病因。预防医源性损伤和及时应用姑息治疗与对潜在ILD的特异性治疗同样重要。